KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Current Deferred Revenue: 2009-2024

Historic Current Deferred Revenue for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $283.0 million.

  • Charles River Laboratories International's Current Deferred Revenue fell 5.65% to $237.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $237.7 million, marking a year-over-year decrease of 5.65%. This contributed to the annual value of $283.0 million for FY2024, which is 3.66% up from last year.
  • Latest data reveals that Charles River Laboratories International reported Current Deferred Revenue of $283.0 million as of FY2024, which was up 3.66% from $273.0 million recorded in FY2023.
  • Over the past 5 years, Charles River Laboratories International's Current Deferred Revenue peaked at $283.0 million during FY2024, and registered a low of $207.9 million during FY2020.
  • Moreover, its 3-year median value for Current Deferred Revenue was $273.0 million (2023), whereas its average is $273.4 million.
  • Data for Charles River Laboratories International's Current Deferred Revenue shows a peak YoY grew of 21.03% (in 2020) over the last 5 years.
  • Charles River Laboratories International's Current Deferred Revenue (Yearly) stood at $207.9 million in 2020, then rose by 5.66% to $219.7 million in 2021, then climbed by 20.28% to $264.3 million in 2022, then climbed by 3.31% to $273.0 million in 2023, then climbed by 3.66% to $283.0 million in 2024.